Delivery Order SPE2DB24D1007-SPE2DB24FCABG

Award Date 8/7/24
Potential Completion Date 8/8/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,102.14 for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The contract is a firm fixed-price agreement with the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 27, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML. The contract, valued at $5,099.03, is a delivery order issued by the Defense Logistics Agency (DLA), a defense agency. The contract has a firm fixed price pricing type and an ultimate completion date of December 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceutical product to the Defense Logistics Agency (DLA). The contract, valued at $2,757.27, is a Firm Fixed Price Delivery Order with a completion date of July 9, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA). The $8,003.82 firm-fixed-price delivery order is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a diabetes medication. The contract has an ultimate completion date of June 9, 2025 and is not set aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a prescription medication, to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $5,224.86, is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The award, valued at $1,879.98, is a Firm Fixed Price Delivery Order contract with a completion date of December 26, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The $1,842.17 Firm Fixed Price contract was awarded by the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract has an ultimate completion date of April 30, 2024 and was awarded on April 29, 2024. This appears to be a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication to the Defense Logistics Agency (DLA). The $4,350.63 firm-fixed-price delivery order has a completion date of December 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies, including...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,422.79 firm-fixed-price delivery order is for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a prescription medication. The contract has an ultimate completion date of November 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $62,944.66 firm-fixed-price delivery order is for OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a prescription medication. The contract has a completion date of June 21, 2024. Amerisourcebergen is the prime contractor, and the contract is not designated as a set-aside. The award is associated with a larger $999,999,999 Indefinite...
  • SPE2DB24D1007
    Indefinite Delivery Contract
  • SPE2DB24D1007-SPE2DB24FCABG
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corp's Corporate Office division is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML prescription medication. The $12,448.12 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA to procure a comprehensive range of medical commodities from AmerisourceBergen to support military treatment programs and facilities worldwide. The contract has no set-aside designation and the ultimate completion date is August 8, 2024.

Generated 11/6/24, 9:29 AM